Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterfeit products. Residents have reportedly been hospitalized with…
Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterfeit products. Residents have reportedly been hospitalized with…Read more… Read More eli lilly and company, health medical pharma, semaglutide, insulin, glucagon like peptide 1 receptor agonist, pharmaceutical industry, eli lilly, counterfeit consumer good, anti obesity medication, type 2 diabetes, obesity, medication, diabetes, peptide hormones Gizmodo
